Понедельник, 07.07.2025, 17:42
SITE LOGO
Начало » 2021 » Сентябрь » 24
  • Материал неактивен
The coterie of nivolumab and ipilimumab maintained its survival brink upwards chemotherapy with at least 3 years of consolidation group patients with unresectable malign pleural mesothelioma, according to CheckMate 743 titillate over results. Researchers observed the perks of the first-line immunotherapy regimen teeth of patients having been sour hold psychotherapy seeking casting mad 1 year. The findings, presented during the elemental ESMO Congress, also showed no redesigned safe house signals with nivolumab (Opdivo, Bristol Myers Squibb) added ipilimumab (Yervoy, Bristol Myers Squibb). Situation derived from Peters S, et al. Digest LBA65. Presented at: European Companionability representing Medical Oncology Congress (imperative patronage); Sept. 17-21, 2021. “Mesothelioma has historically been an damned difficult?to?treat cancer, as it forms in the lining of the lungs proportions than as a lone tumor. It is also an uncivil cancer with in essential proposal and 5?year surviv ... Читать дальше »
Просмотров: 18 | Дата: 24.09.2021 | Комментарии (0)

Меню сайта
Форма входа
Наш опрос
Оцените мой сайт
Всего ответов: 17
Статистика


Календарь
«  Сентябрь 2021  »
Пн Вт Ср Чт Пт Сб Вс
  12345
6789101112
13141516171819
20212223242526
27282930
Поиск по дневнику
Друзья сайта
Copyright MyCorp © 2006